154 related articles for article (PubMed ID: 21462477)
1. [Genetic risk markers of low bone mineral density in cystic fibrosis children].
Norek A; Sands D; Sobczyńska-Tomaszewska A; Chmielewski D; Szamotulska K; Czerska K; Bal J
Med Wieku Rozwoj; 2010; 14(4):334-43. PubMed ID: 21462477
[TBL] [Abstract][Full Text] [Related]
2. The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes.
Castellani C; Malerba G; Sangalli A; Delmarco A; Petrelli E; Rossini M; Assael BM; Mottes M
J Cyst Fibros; 2006 Dec; 5(4):229-35. PubMed ID: 16713399
[TBL] [Abstract][Full Text] [Related]
3. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
[TBL] [Abstract][Full Text] [Related]
4. Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men.
Braga V; Sangalli A; Malerba G; Mottes M; Mirandola S; Gatti D; Rossini M; Zamboni M; Adami S
Calcif Tissue Int; 2002 Jun; 70(6):457-62. PubMed ID: 12016463
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral density.
Eckstein M; Vered I; Ish-Shalom S; Shlomo AB; Shtriker A; Koren-Morag N; Friedman E
Isr Med Assoc J; 2002 May; 4(5):340-4. PubMed ID: 12040821
[TBL] [Abstract][Full Text] [Related]
6. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
7. [Bone density and bone metabolism regulated by vitamin D receptor allele polymorphism in a German study sample].
Baltzer AW; Reinecke J; Wehling P; Granrath M; Schulitz KP
Z Orthop Ihre Grenzgeb; 1999; 137(3):273-9. PubMed ID: 10441835
[TBL] [Abstract][Full Text] [Related]
8. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.
King SJ; Topliss DJ; Kotsimbos T; Nyulasi IB; Bailey M; Ebeling PR; Wilson JW
Eur Respir J; 2005 Jan; 25(1):54-61. PubMed ID: 15640323
[TBL] [Abstract][Full Text] [Related]
9. [High prevalence of osteoporosis in adult cystic fibrosis patients].
Lang SM; Fischer R; Stratakis DF; Huber RM
Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1551-5. PubMed ID: 15243902
[TBL] [Abstract][Full Text] [Related]
10. [Decreased bone mineral density and gene polymorphism in primary biliary cirrhosis].
Lakatos PL; Bajnok E; Tornai I; Folhoffer A; Horváth A; Lakatos P; Szalay F
Orv Hetil; 2004 Feb; 145(7):331-6. PubMed ID: 15049048
[TBL] [Abstract][Full Text] [Related]
11. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.
Rubin LA; Hawker GA; Peltekova VD; Fielding LJ; Ridout R; Cole DE
J Bone Miner Res; 1999 Apr; 14(4):633-43. PubMed ID: 10234586
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphisms.
Ferrari S; Rizzoli R; Manen D; Slosman D; Bonjour JP
J Bone Miner Res; 1998 Jun; 13(6):925-30. PubMed ID: 9626623
[TBL] [Abstract][Full Text] [Related]
13. Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms.
Tantawy AA; El Bostany EA; Matter RM; El Ghoroury EA; Ragab S; El Sherif NH
Platelets; 2013; 24(4):282-7. PubMed ID: 22671537
[TBL] [Abstract][Full Text] [Related]
14. Accrual of Bone Mass in Children and Adolescents With Cystic Fibrosis.
Sharma S; Jaksic M; Fenwick S; Byrnes C; Cundy T
J Clin Endocrinol Metab; 2017 May; 102(5):1734-1739. PubMed ID: 28323913
[TBL] [Abstract][Full Text] [Related]
15. [Bone mass in patients with cystic fibrosis of the pancreas. Relationship with anthropometric parameters and genotype].
Yeste D; Liñán S; Cobos N; Gussinyé M; del Río L; Carrascosa A
Med Clin (Barc); 1998 Oct; 111(13):485-8. PubMed ID: 9859064
[TBL] [Abstract][Full Text] [Related]
16. Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.
Parés A; Guañabens N; Alvarez L; De Osaba MJ; Oriola J; Pons F; Caballería L; Monegal A; Salvador G; Jo J; Peris P; Rivera F; Ballesta AM; Rodés J
Hepatology; 2001 Mar; 33(3):554-60. PubMed ID: 11230734
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of polymorphism of bone metabolism genes and evaluation of the risk of osteopenia in cosmonauts].
Oganov VS; Baranov VS; Kabitskaia OE; Novikov VE; Bakulin AV; Moskalenko MV; Aseev MV; Voĭtulevich LV
Aviakosm Ekolog Med; 2010; 44(3):18-23. PubMed ID: 21033393
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the vitamin D receptor gene and corticosteroid-related osteoporosis.
Ho YV; Briganti EM; Duan Y; Buchanan R; Hall S; Seeman E
Osteoporos Int; 1999; 9(2):134-8. PubMed ID: 10367040
[TBL] [Abstract][Full Text] [Related]
19. The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.
Stathopoulou MG; Dedoussis GV; Trovas G; Theodoraki EV; Katsalira A; Dontas IA; Hammond N; Deloukas P; Lyritis GP
J Nutr Biochem; 2011 Aug; 22(8):752-7. PubMed ID: 21115334
[TBL] [Abstract][Full Text] [Related]
20. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?
Ferrari SL; Rizzoli R; Slosman DO; Bonjour JP
J Bone Miner Res; 1998 Mar; 13(3):363-70. PubMed ID: 9525336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
